Jon Ruben Email & Phone Number

Florida, United States

Lead the commercial strategy and execution for Citius Oncology (start-up) across a vast region spanning from Maine to Florida, representing half of the United States' potential. My focus is on building and scaling our presence within the Cutaneous T-Cell Lymphoma (CTCL) market. Key Responsibilities & Accomplishments:• Hiring, developing, and leading a high-performing Key Account Management (KAM) team dedicated to maximizing regional potential in academic and community settings.• Collaborating with internal stakeholders to build out commercial capabilities that support the successful launch and promotion of Lymphir, our first FDA-approved product.• Fostering a collaborative culture across the cross-functional field team that aligns with the organization's strategic goals and mission.• Leveraging enterprise-level insights and approach to optimize outcomes.• Developing strategic partnerships and cultivating relationships with top academic centers, influential community practices, and key opinion leaders (KOL’s) to drive adoption of our innovative therapies.• Spearheading the launch of Lymphir (a rare hematologic disease), driving market adoption through strategic planning and targeted engagement.• Ensuring patient access to Lymphir by leveraging HUB services and internal resources throughout the patient’s journey. LYMPHIRTM is a novel immunotherapy for the treatment of relapsed or refractory (r/r) cutaneous T-cell lymphoma (CTCL), a rare form of non-Hodgkin lymphoma. On August 7, 2024, the FDA approved LYMPHIR (denileukin diftitox-cxdl) for the treatment of adult patients with relapsed or refractory Stage I-III CTCL after at least one prior systemic therapy.

VAIL (Vision, Authentic, Inspirational Leadership) -Healthcare consulting in commercial strategy and transformational leadership within the life sciences industry. Working with high-growth and start-up clients who are at the cutting edge of innovation as well as those that want to grow and defend an established portfolio. Tailoring solutions to meet clients’ unique needs. Selected Achievements:*• Generated over $445,000 in gross revenue - 2022• Developed customized training initiatives for field commercial sales (POA), leadership, operations, and matrix teams within the biopharma and medical device segments• Provided a wide range of expert witness services to several biotech’s and major pharmaceutical companies to model, analyze, develop solutions, and resolve complex marketplace commercial issues

Lawrence Township, Nj, Us

Led a region of 7 District Business Managers and 65 Territory Business Managers in the east half of the country. Launched an MS drug in the rare disease space utilizing a specialty pharmacy/HUB distribution network. Integrated Celgene and developed a One Immunology Culture across the BU. Point Roles include: Leadership Development (1st & 2nd Line) across all divisions, Diversity & Inclusion, and Sales Leadership Society. Organizational restructure in 5/2021.Selected Achievements:*Launched ZEPOSIA for multiple sclerosis to key Centers of Excellence and community neurology practices*Led nation in growth - new patient starts 2021

Lawrence Township, Nj, Us

Led a region of 10 District Business Managers and 108 Territory Business Managers, throughout 8 states in the southeast, within the Hospital and Specialty (Cardiology, EP, Hem/ONC, Pulmonary, Vascular) Retail segments. Grew business from launch to over $1 billion in annual sales. National Point role(s) for IDN Strategy, Regional Account Executives, Incentive Compensation, New Business Development, Marketing Liaison, Leadership Development and Alliance Work Streams on the Institutional Expansion (Operations, Sales Learning, IC, Communications, Marketing Resources, Launch Plan, Goals/Metrics). Selected Achievements:*Won Winners Circle Trip to Kauai, Hawaii -2018 *Won Winner’s Circle Trip to Rome -2017*Won Pinnacle Trip to Whistler BC - 2016*Won Pinnacle Trip to Maui, Hawaii -2015*Won Pinnacle Trip to Punta Cana -2014*Won Pinnacle Trip to Grand Cayman -2013*Won Launch Pinnacle Trip to Lanai, Hawaii - 2013*Won Pinnacle Trip to Kauai, Hawaii - 2012•#1 in key market segmentations – sales volume per physician target•Improved regional ranking from 6th place to Pinnacle Winner - 2011

Strategically led a region of 7+ Sales Managers and 65+ Representatives throughout 5 states in the Southeast U.S. and Puerto Rico. Region led the country in sales due to our focus on market segmentations, essential distribution channels, maximization of organizational resources, development of top KOL’s and customization of business solutions for high volume healthcare providers. Selected Achievements:• #1 in goal attainment for Embeda® - 2011 YTD• #1 in goal attainment for Embeda® - 2010• Won President’s Club - 2009• #1 in key market segmentations – sales volume per physician target• Promoted 14 employees • Launched first-in-class CII

Led a team of Hospital Sales Specialists throughout the Southeast U.S. Outpaced the country in sales of the Thrombin-JMI® Family of Products by promoting Thrombin-JMI® (biologic), Thrombi-Pad® (device), and Thrombi-Gel® (device) in the OR, ED and ICU’s respectively. Developed and executed on a segmentation strategy based on account penetration of sales vs. procedures. Effectively partnered with KOL’s in Ortho, Neuro, Trauma, Thoracic and Vascular Departments. Selected Achievements:• Won President’s Club - 2008• #1 in the nation for goal attainment (112.6%) with 99% market share - 2008• Launched 2 medical devices – full distribution, hospital VAC approvals, sales pull through• Created a corporate strategy for local, regional and national health-systems.

Strategically grew sales and profit of PROCRIT (injectable) and DOXIL (infused) in the hospital and clinic segments from $70 million to $115 million annually. Recruited, trained and motivated 8 Product Specialists/Territory Managers. Led the development and role-out of a national clinic business plan. Drove growth of company revenues by introducing business solutions that maximized practice/institutional revenues, decreased practice/institutional expenses and improved patient outcomes in the oncology and surgical indications. Launched CellSearch technologies (diagnostics) to key clinic customers in Florida. Mentored over 10 Managers/Directors/Representatives.Selected Achievements:• $295 million in sales over three years - $100 million more than #2 district• #1 district in the nation in all categories for 24 months - unprecedented• #1 district in the region for 36 months - unprecedented• President’s Cup, 2003, 2004, 2005 – Top 10% of the country• Infinity Cup, 2003, 2004, 2005 – Best District in the Region

Contributed to the development of brand business plan and was responsible for: Development of promotional materials, CEU programs, and HOPE Speakers Bureau which targeted the hospital setting (i.e. ICU, Oncology & Nephrology floors, pharmacy and surgical suites). Coordinated and managed pharmacy conventions. Balanced the marketing P&L ($9 million). Selected Achievements:• Broke attendance records for ASHP CEU programs and booth traffic (~600 & ~6000 respectively). • Delivered over 10 major selling tools for the field sales force. (Core visual aids, CEU programs, etc.)• Delivered 350 Speaker Programs through KOL thought leaders

Developed communication tools to improve synergy within operating companies worldwide by sharing best practices and leveraging key learning. Included: e-biz News 4 Pharma – improved competitive immunity, Worldwide Pharma eNews – showcased key J&J Pharma e-Initiatives, ePharma Website – collection of worldwide J&J e-InitiativesSelected Achievements:•Established a Global Resource for the eLeadership Across the Pharma and Biotech Sector.

Developed and implemented initial and ongoing training programs for Franchise. Trained over 1000 representatives in two franchises and two companies. Developed training tools for product knowledge REGRANEX®, ORTHO-PREFEST®, and LEVAQUIN®, for the LTC, HHC, Hospital and MCO markets. Worked with two brands creating strategy and tactics for marketing business plans. Launched ORTHO-PREFEST®. Selected Achievements:• Won Johnson & Johnson Achievement Award two times• Won Peak Award five times

Increased sales and profit for start-up franchise within company. Recruited, trained and motivated 14 sales representatives. Launched and sold new biologic REGRANEX®, sold LEVAQUIN®, and ULTRAM®Selected Achievements:• Lead region in sales with over $2.9 million • Assisted in development of Franchise Incentive & Recognition program• Elected by peers to position in Management Advisory Board (MAB)• Promoted to Franchise Training Manager.

Bs, Management

Strategic Marketing

Leadership Development Program